Focused Wealth Management, Inc - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,849
+5.9%
400.0%0.00%0.0%
Q2 2023$4,581
-16.9%
400.0%0.00%0.0%
Q1 2023$5,513
-71.6%
40
-73.3%
0.00%
-75.0%
Q4 2022$19,437
+14.3%
1500.0%0.00%0.0%
Q3 2022$17,000
-26.1%
150
-51.9%
0.00%0.0%
Q2 2022$23,000
-4.2%
312
-0.3%
0.00%0.0%
Q1 2022$24,000
-91.0%
313
-89.5%
0.00%
-90.2%
Q4 2021$267,000
-14.1%
2,969
-11.7%
0.04%
-19.6%
Q3 2021$311,000
+10.7%
3,362
-7.0%
0.05%
+10.9%
Q2 2021$281,000
-6.3%
3,615
-10.1%
0.05%
-13.2%
Q1 2021$300,000
+11.1%
4,022
+153.9%
0.05%0.0%
Q4 2020$270,000
+2.3%
1,584
-15.7%
0.05%
-7.0%
Q3 2020$264,000
-77.6%
1,878
-74.4%
0.06%
-79.1%
Q2 2020$1,177,000
+62.3%
7,343
-1.0%
0.27%
+30.6%
Q1 2020$725,000
-24.8%
7,416
-0.7%
0.21%
-8.3%
Q4 2019$964,000
+57.8%
7,469
-8.0%
0.23%
+34.9%
Q3 2019$611,000
-55.7%
8,116
-10.6%
0.17%
-54.2%
Q2 2019$1,380,000
+15.7%
9,080
-9.3%
0.37%
+2.2%
Q1 2019$1,193,000
+11.9%
10,006
+2.5%
0.36%
-0.8%
Q4 2018$1,066,000
-28.1%
9,766
+6.4%
0.36%
-27.9%
Q3 2018$1,483,0009,1810.50%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders